Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Receivables - Other (2017 - 2025)

Updated

Moderna (MRNA) posted Receivables - Other of $61 million for Q2 2025, up 90.6% from the prior quarter.

Analysis

Moderna (MRNA) Receivables - Other (2017 - 2025) Analysis & Trends

At the end of FY2024, Moderna's Receivables - Other came in at $20 million.

  • Annual Receivables - Other shows a five-year compound annual growth rate of 126.3% (FY2019 to FY2024).
  • The Q2 2025 figure stands as the highest quarterly Receivables - Other in data going back to Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 61.00 Mn
Mar 31, 2025 32.00 Mn
Dec 31, 2024 20.00 Mn
Mar 31, 2020 1.68 Mn
Dec 31, 2019 337,000.00
Sep 30, 2019 5.42 Mn
Jun 30, 2019 1.02 Mn
Mar 31, 2019 965,000.00
Dec 31, 2018 899,000.00
Dec 31, 2017 1.54 Mn
API Access

Moderna Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=MRNA&period=max&api_key=YOUR_API_KEY